Omvoh 300 mg, solution à diluer pour perfusion
7680689500010
CH-68950
Lösung
Associated product:
OMVOH conc perf 300 mg/15ml flac 15 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Lösung
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
60.02 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1248.20
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/08/2024
Authorization holder
Eli Lilly (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 68950
- Drug name
- Omvoh, solution à diluer pour perfusion
- Galenic form
- KOINF
- ATC Code
- L04AC24
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 30/11/2023
- Authorization expiration date
- 29/11/2028
- IT Number
- 07.15.0.
- Domain
- Human medicine
Package details
- Description (FR)
- OMVOH conc perf 300 mg/15ml flac 15 ml
- Description (DE)
- OMVOH Inf Konz 300 mg/15ml Durchstf 15 ml
- Market launch
- 30/11/2023
- Narcotic (BTM)
- No